| Sarcomatoid Renal Cell Carcinoma studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03055013Phase 3 · active not recruiting Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06866262Phase 1/Phase 2 · recruiting Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial · condition mapped CURATED_BROADER · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049576Phase 1 · active not recruiting Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128680Phase 1 · recruiting Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer · condition mapped CURATED_BROADER · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447103Phase 2 · recruiting An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07037004Phase 2 · recruiting Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05808608Phase 1/Phase 2 · active not recruiting A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05122546Phase 1 · active not recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218692Phase 2 · not yet recruiting RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · condition mapped CURATED_BROADER · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03685448Phase 2 · completed ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767636Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399419Phase 1 · recruiting CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer · condition mapped CURATED_BROADER · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068393Phase 2 · completed Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma · condition mapped ALIAS · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664182Phase 2 · completed Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer · condition mapped CURATED_BROADER · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03177239Phase 2 · unknown Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126503Phase 1/Phase 2 · completed Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 21 trials mapped (14 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |